"PPAR-beta" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
One of the PPAR nuclear transcription factors.
Descriptor ID |
D048068
|
MeSH Number(s) |
D12.776.826.239.530
|
Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "PPAR-beta".
Below are MeSH descriptors whose meaning is more specific than "PPAR-beta".
This graph shows the total number of publications written about "PPAR-beta" by people in this website by year, and whether "PPAR-beta" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
2005 | 3 | 0 | 3 |
2006 | 2 | 0 | 2 |
2007 | 6 | 0 | 6 |
2008 | 9 | 1 | 10 |
2009 | 5 | 1 | 6 |
2010 | 2 | 1 | 3 |
2011 | 3 | 0 | 3 |
2012 | 2 | 0 | 2 |
2014 | 3 | 0 | 3 |
2015 | 1 | 0 | 1 |
2016 | 2 | 0 | 2 |
2017 | 2 | 0 | 2 |
2018 | 1 | 0 | 1 |
2019 | 1 | 0 | 1 |
2024 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "PPAR-beta" by people in Profiles.
-
Zhu B, Zhu X, Borland MG, Ralph DH, Chiaro CR, Krausz KW, Ntambi JM, Glick AB, Patterson AD, Perdew GH, Gonzalez FJ, Peters JM. Activation of Peroxisome Proliferator-Activated Receptor-?/d (PPAR?/d) in Keratinocytes by Endogenous Fatty Acids. Biomolecules. 2024 May 21; 14(6).
-
Peters JM, Kim DJ, Bility MT, Borland MG, Zhu B, Gonzalez FJ. Regulatory mechanisms mediated by peroxisome proliferator-activated receptor-?/d in skin cancer. Mol Carcinog. 2019 09; 58(9):1612-1622.
-
Borland MG, Kehres EM, Lee C, Wagner AL, Shannon BE, Albrecht PP, Zhu B, Gonzalez FJ, Peters JM. Inhibition of tumorigenesis by peroxisome proliferator-activated receptor (PPAR)-dependent cell cycle blocks in human skin carcinoma cells. Toxicology. 2018 07 01; 404-405:25-32.
-
Yao PL, Morales JL, Gonzalez FJ, Peters JM. Peroxisome proliferator-activated receptor-?/d modulates mast cell phenotype. Immunology. 2017 04; 150(4):456-467.
-
Yao PL, Chen L, Dobrzanski TP, Zhu B, Kang BH, M?ller R, Gonzalez FJ, Peters JM. Peroxisome proliferator-activated receptor-?/d inhibits human neuroblastoma cell tumorigenesis by inducing p53- and SOX2-mediated cell differentiation. Mol Carcinog. 2017 05; 56(5):1472-1483.
-
Koga T, Yao PL, Goudarzi M, Murray IA, Balandaram G, Gonzalez FJ, Perdew GH, Fornace AJ, Peters JM. Regulation of Cytochrome P450 2B10 (CYP2B10) Expression in Liver by Peroxisome Proliferator-activated Receptor-?/d Modulation of SP1 Promoter Occupancy. J Biol Chem. 2016 Nov 25; 291(48):25255-25263.
-
Balandaram G, Kramer LR, Kang BH, Murray IA, Perdew GH, Gonzalez FJ, Peters JM. Ligand activation of peroxisome proliferator-activated receptor-?/d suppresses liver tumorigenesis in hepatitis B transgenic mice. Toxicology. 2016 07 01; 363-364:1-9.
-
Peters JM, Gonzalez FJ, M?ller R. Establishing the Role of PPAR?/d in Carcinogenesis. Trends Endocrinol Metab. 2015 Nov; 26(11):595-607.
-
Zhu B, Ferry CH, Markell LK, Blazanin N, Glick AB, Gonzalez FJ, Peters JM. The nuclear receptor peroxisome proliferator-activated receptor-?/d (PPAR?/d) promotes oncogene-induced cellular senescence through repression of endoplasmic reticulum stress. J Biol Chem. 2014 Jul 18; 289(29):20102-19.
-
Borland MG, Krishnan P, Lee C, Albrecht PP, Shan W, Bility MT, Marcus CB, Lin JM, Amin S, Gonzalez FJ, Perdew GH, Peters JM. Modulation of aryl hydrocarbon receptor (AHR)-dependent signaling by peroxisome proliferator-activated receptor ?/d (PPAR?/d) in keratinocytes. Carcinogenesis. 2014 Jul; 35(7):1602-12.